相关实验视频

Updated: Jul 20, 2026

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Imaging Features of Systemic Sclerosis-Associated Interstitial Lung Disease

Published on: June 16, 2020

在患有全身性硬化症的患者中,评估胆道血管度指数和胆道厚度

Esra Vural¹, Kemal Erol², Nurettin Bayram^3,4

¹World Eye Hospital, Istanbul, Turkey. vural_esra@yahoo.com.

International ophthalmology

|May 8, 2025

概括

系统性硬化症 (SSc) 患者表现出胆管厚度和胆管血管指数 (CVI) 的降低,这可能表明血管损伤. 这些发现突显了与SSc相关的眼部变化,特别是其纤维化和血管病变的表现.

科学领域:

眼科医生眼科眼科
类风湿病学类风湿病学
血管生物学血管生物学

背景情况:

系统性硬化症 (SSc) 是一种结缔组织疾病,其特征是纤维化和血管病变.
在SSc中可能会影响眼部微血管,但对胆道结构的全面评估是有限的.

研究的目的:

在SSc患者和健康对照者之间比较冠状腺结构成分,包括中央黄斑厚度 (CMT),冠状腺厚度 (CT) 和冠状腺血管指数 (CVI).
调查胸腔发现与SSc严重性的临床标记之间潜在的相关性,例如指甲视频毛囊显微镜 (NVC) 和修改的罗丹皮肤评分 (mRss).

主要方法:

一项前性比较研究,涉及22名SSc患者和21名健康对照.
眼相干断层扫描 (OCT) 用于测量CMT,CT和CVI.
专家风湿病学家对NVC和mRss进行了评估,以评估疾病严重程度和血管状况.

主要成果:

与对照组相比,患有SSc的患者表现出明显减少的亚叶,叶和鼻腔冠状腺厚度.
在不同测量区域的SSc患者中,冠状血管指数 (CVI) 显着较低.
在CMT,CVI或CT和mRss或雷诺症严重程度之间没有发现显著的相关性,尽管mRss与雷诺症严重程度有积极的相关性.

结论:

在患有全身性硬化症的患者中,冠状腺厚度和CVI降低.
降低CVI可能是SSc血管损伤的潜在指标,特别是影响光线结构.
这些发现表明,眼睛的微血管变化,特别是胸膜,与SSc.有关.

关键词:

冠状动脉血管度指数冠状动脉血管度指数指甲折叠毛细管镜检查指甲折叠毛细管镜检查指甲折叠毛细管镜检查指甲折叠毛细管镜检查指甲折叠毛细管镜检查指甲折叠毛细管镜检查指甲折叠毛细管镜系统性硬化症系统性硬化症

更多相关视频

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography

Evaluation of Capillary and Other Vessel Contribution to Macular Perfusion Density Measured with Optical Coherence Tomography Angiography

Published on: February 18, 2022

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Determining Gender-Based Differences in Retinal and Choroidal Thickness in Underweight Individuals via Swept-Source Optical Coherence Tomography

Published on: December 1, 2023

相关概念视频

Assessment of the Cardiovascular System II: Inspection

Assessment of the Cardiovascular System II: Inspection

Inspection is the initial step in assessing the cardiovascular system. It involves a detailed visual examination that provides crucial information about a patient's circulatory and cardiac health. This systematic process, conducted from head to toe, helps identify signs of cardiovascular conditions by observing physical appearance, skin and mucous membranes, jugular and carotid pulsations, chest symmetry, and the condition of the extremities.
Head and Neck

Assessment of the Cardiovascular System III: Palpation

Assessment of the Cardiovascular System III: Palpation

Palpation involves feeling the body to evaluate texture, size, consistency, and tenderness for assessing cardiovascular health. The following steps are organized in a head-to-toe order:
Jugular Venous Pressure (JVP) Measurement
Position the patient at a thirty- to forty-five-degree angle or in a semi-fowler's position. Look for the highest point of pulsation in the internal jugular vein and measure the vertical distance to the angle of Loius or sternal angle. A normal JVP is 3-4 cm above the...

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Imaging Studies for Cardiovascular System VI: Calcium -Scoring CT

Calcium-Scoring CT ScanA calcium-scoring CT scan, also known as coronary artery calcium (CAC) scan, detects calcium deposits in the coronary arteries. This test assesses the risk of coronary artery disease (CAD), which can lead to cardiovascular events such as angina, heart failure, and sudden cardiac arrest.A calcium-scoring CT scan is generally recommended for individuals at intermediate risk of CAD without symptoms. It includes:Men aged 40-75 and women aged 50-75: Especially those with a...

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis II: Clinical Manifestations and Diagnostic Tests

Atherosclerosis is a progressive disorder that leads to the thickening and narrowing of arterial walls due to plaque buildup. This condition can cause various symptoms depending on the arteries affected:Coronary Artery Disease (CAD): This condition affects the coronary arteries and may lead to chest pain (angina), shortness of breath (dyspnea), heart attacks, and other heart disease symptoms.Cerebrovascular Disease: This affects blood flow to the brain, causing transient ischemic attacks (TIAs)...

Peripheral Artery Disease I: Introduction

Peripheral Artery Disease I: Introduction

Peripheral artery disease (PAD) predominantly results from atherosclerosis, which involves the accumulation of fatty deposits, or plaques, within the walls of arteries. This causes them to narrow and harden, significantly reducing blood flow. PAD predominantly affects the legs, particularly the arteries supplying the thighs and calves. In rare cases, it may involve other arteries, including those in the arms.Etiology of PAD:The principal cause of PAD is atherosclerosis, which results from fatty...

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Peripheral Arterial Disease II: Clinical Manifestations and Diagnostic Evaluation

Clinical manifestationsPeripheral Arterial Disease (PAD) manifests through a range of symptoms, from the characteristic intermittent claudication to atypical presentations and severe complications in advanced stages. Intermittent claudication, a hallmark symptom of PAD, presents as exercise-induced muscle pain that typically resolves within minutes of rest. This pain is reproducible and stems from inadequate blood flow, leading to the accumulation of lactic acid produced during anaerobic...